Boxer Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Boxer Capital’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-570,745	Closed	-$42.9M	–	82
2022 Q2	$42.9M	Buy	570,745 +170,745	+43%	+$7.59M	2.72%	13
2022 Q1	$10.7M	Buy	+400,000	New	+$13.4M	0.55%	44
2021 Q4	–	Sell	-525,000	Closed	-$34.9M	–	94
2021 Q3	$34.9M	Buy	+525,000	New	+$37.4M	1.22%	26

Boxer Capital's TPTX Position: Q3 2022 in Review

Boxer Capital sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 570,745 shares — an estimated $42.9M sold.

Boxer Capital first reported a position in TPTX in Q3 2021 and held it in 3 quarters. The position peaked at $42.9M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Boxer Capital reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Boxer Capital sold 570,745 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $42.9M.
Boxer Capital first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Boxer Capital's Turning Point Therapeutics, Inc. Common Stock position peaked at $42.9M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Boxer Capital's 13F filing for Q3 2022, filed 14 Nov 2022.